Aged Care Psychotropic Medication Registers: Use case and AI Confidentiality

Many aged care homes keep a psychotropic register: one row for every resident on an antipsychotic, antidepressant or sedative, with the reason, whether it counts as chemical restraint, who consented and when the doctor will review it. Clinical managers paste the sheet into ChatGPT or Claude before a GP round to ask which rows look wrong, or to count the chemical restraints for a report. The register puts five residents’ mental health and medicines on one screen, with a guardian’s name and a row that may be an unreported restrictive practice. This page marks every cell that matters in a realistic psychotropic medication register and shows how the same sheet is checked on Ermos.

The psychotropic medication register

Kept by the clinical manager or lead registered nurse, updated whenever a psychotropic is started, changed or stopped, and taken to each GP round and medication review.

Psychotropic medication register
Kurrajong Gardens Aged Care · Wattle wing · As at Monday 16 November 2026 · Kept by B. Santos RN

fx=COUNTIF(E2:E6,"Yes")
ABCDEFGHI
1RoomResidentMedicine and doseRecorded reasonChemical restraint?ConsentLast reviewNext reviewNotes
214B18 Oct, Dr Nair13 DecContinue 8 weeks. Pharmacist review 9 Nov, no change. Give whole in puree.
37AMr Vass, himself2 Oct, Dr Nair8 Jan 2027Mood better. Back at chapel on Sundays.
413BMrs Whitbread, herself4 Nov, Dr Nair3 Feb 2027Gastro 6 to 7 Nov. Reweigh this week.
57BNot since admissionDr Nair, Wed 18 Nov
66BMrs Walmsley, herself, for anxiety-Dr Nair, Wed 18 Nov
7CountResidents listed
8Rule
WattleConsents

An invented register. The residents, medicines, doses and dates are invented. Hover or tap any highlighted cell for the analysis; the full list is below.

Psychotropic register reviewer

An Agent+ that compares the psychotropic register with the current orders and the diagnoses on file. It highlights entries with no recorded classification or reason, and prepares a list of questions for each GP round and medication review.

What it does

  1. Reads the register, the orders and the diagnoses
  2. Compares each entry with your classification checklist
  3. Prepares a list of gaps for the GP round

What stays with your people. The clinical manager or lead registered nurse classifies each entry, and the GP decides on any medicine. The agent flags; it does not classify.

An Agent+ is built once and anyone in the practice can run it. It works from your own documents and runs on Ermos Dominion, the AI unit in your office, or on Ermos Edge, your own instance in an Australian data centre.

What leaves the service

  1. 1
    Five residents, by name and room

    Five people identified at once. Each is someone whose personal information section 168 of the Aged Care Act 2024 requires the home to protect, and the register shows a whole wing’s psychotropic medicines in a single paste. Privacy Act guide.

  2. 2
    Medicines and doses

    Two antipsychotics, two antidepressants and a sedative, with doses and times. Health information, which is sensitive information under section 6(1) of the Privacy Act. Outcome 5.3 says medicines are administered, monitored and reviewed by registered health practitioners (rule 15-30(6)(b) of the Aged Care Rules 2025), and a tool that copies a dose wrongly creates an order nobody gave. Patient data guide.

  3. 3
    Diagnoses and reasons

    Depression, anxiety and behaviours, with who diagnosed them and when. Mental health information about named residents is among the most sensitive health information a home holds. The recorded reason also drives the next column, because rule 17-5(2) excludes medication prescribed to treat a diagnosed mental disorder from chemical restraint. Patient data guide.

  4. 4
    The chemical restraint column

    A yes or no for each resident. Rule 17-5(2) defines chemical restraint by the primary purpose of the medication, which is for the prescriber and the home to judge on the facts. A tool can restate the definition and cannot classify a resident. Patient data guide.

  5. 5
    A guardian’s consent

    A named daughter, her role and the date of her written consent. Rule 162-15(1)(f) requires informed consent from the resident or, if she lacks capacity, her restrictive practices substitute decision-maker, and rule 162-25(1)(a)(iv) requires the home to be satisfied that the prescriber obtained informed consent to prescribing for chemical restraint. Personal information about someone who is not a resident. Privacy Act guide.

  6. 6
    The row nobody has classified

    A sedating antipsychotic with a vague reason, no consent and no plan, and night staff charting behaviour. If its main purpose is to influence behaviour, rule 162-25 requires a medical or nurse practitioner’s assessment, a prescription for that purpose and consent, all documented in a behaviour support plan. Section 16(1)(g) of the Act makes use of a restrictive practice outside the rules a reportable incident. The row records a possible compliance gap and the manager’s knowledge of it.

  7. 7
    A when-needed sedative and its reasons

    A sedative charted for anxiety and given three times for calling out at night. Rule 162-25(1)(c) requires chemical restraint to be used in accordance with the prescription documented in the behaviour support plan, and rule 162-30(e) requires information about its effects and use to go back to the prescriber. Whether these doses were treatment or restraint is for the doctor and the home to work out. Patient data guide.

  8. 8
    The count and the formula

    Five residents and one confirmed chemical restraint. The formula counts only cells that read exactly “Yes”, so the unclassified row is left out. A tool asked for the number may count differently, and any figure that leaves the sheet for a report needs checking by a person.

  9. 9
    Other tabs

    A workbook is a whole file. Uploading it sends the Banksia tab, the when-needed log with every dose and reason, and any hidden columns and comments, even when the screen shows only Wattle.

  10. 10
    The definition

    The definition of chemical restraint from rule 17-5(2), as published in the Aged Care Rules 2025. Public legislation with no resident in it.

What happens in Frontier Models (ChatGPT, Claude)

  • The whole document is transmitted to the provider’s servers. On personal plans the user cannot choose where it is stored or processed, and for the major providers that has generally meant outside Australia, under that country’s legal process. Some business plans offer storage in Australia, but the provider still receives the content.
  • On consumer tiers, prompts can be retained and used to train future models.
  • The provider’s staff and systems can reach the content under the provider’s own policies.
  • Once sent, the service no longer controls it. Retention and deletion happen on the provider’s terms.

The same document on Ermos

Ermos Dominion

The document is drafted on a unit in your office, from your own templates and the resident’s record. Every marked item stays on the unit, which keeps working with the internet switched off. Nothing in it is transmitted to an AI provider, so there is no disclosure to analyse: the confidentiality work is the same as for your file server.

Ermos Edge

Your documents, the index and your access boundaries stay on your own instance in an Australian data centre. When a staff member asks for this draft, only their question and the excerpts they are permitted to see go to a named Australian provider, who is contractually barred from keeping the content or training any model on it. Nothing is processed outside Australia.

Frontier Models (ChatGPT, Claude)Ermos EdgeErmos Dominion
Where the document is processedProvider servers, generally offshore on personal plansYour instance in an Australian data centre; answers generated in AustraliaThe unit in your office
Who can read itProvider staff and systems, under policyYour staff, within the boundaries you set. The named Australian provider processes only permitted excerpts, under contract, and keeps nothingYour staff only
Is it keptOn the provider’s termsKept on your instance; the provider is barred from retaining itStays on the unit
Can it train a modelOn consumer tiers, yesNo, by contractOnly your own unit learns from it, on your hardware

Part of Use cases in aged care providers.

Common questions

Do ChatGPT and Claude use the information in a psychotropic medication register?
Every row a clinical manager pastes, or the whole workbook if it is uploaded, is sent to the AI company's servers and processed there to produce a reply. As at October 2026, whether a conversation on a personal plan (ChatGPT Free, Plus or Pro; Claude Free, Pro or Max) can be used to train the models depends on a setting each user controls. Business plans (ChatGPT Business and Enterprise, Claude Team and Enterprise) and the developer APIs sit under commercial terms, and OpenAI and Anthropic each say they do not train on that content by default (OpenAI, Anthropic). On either product, the thumbs up and thumbs down buttons can send a whole conversation back for training. This register sets five residents' names beside their psychotropic medicines and records Carolyn Thornbury-Wu's written consent as enduring guardian. Its quetiapine row may be chemical restraint with no consent and no plan.
Can we use ChatGPT or Claude for a psychotropic medication register if we remove the residents' names?
Not safely, because room numbers, medicines and dates still point to each resident on the Wattle wing. Removing names rarely makes a document anonymous. Information stays personal information while the person is reasonably identifiable, and the OAIC warns that information can be at risk of re-identification even when it has been de-identified or anonymised. Room 7B, with quetiapine for sleep from a discharge list dated 14 October, is one person to any family member or worker. Depression, anxiety and the medicines that treat them are health information, which section 6(1) of the Privacy Act makes sensitive information. The Office of the Australian Information Commissioner (OAIC) recommends in its guidance on commercially available AI products that organisations do not enter personal information, and particularly sensitive information, into publicly available generative AI tools, because of the significant and complex privacy risks.
Can I upload a psychotropic medication register to ChatGPT or Claude instead of pasting it?
Uploading sends more than the screen shows, because a workbook leaves the home as a whole file. It can carry other sheets, hidden columns, comments, tracked changes and file properties. The OAIC's guidance also tells organisations to review carefully the terms and settings that will apply to their use of any AI product. Behind the Wattle tab sit a Banksia tab, a PRN log with every when-needed dose and its reason, and a Consents tab. Asking for one wing's chemical restraint count would send all of them.
How can an aged care home use AI for a psychotropic medication register without sending it to ChatGPT or Claude?
Ermos is built so the document stays under your control. On the Dominion AI unit it is drafted inside your office and none of it is sent to an AI provider. On Ermos Edge your documents and index stay on your own instance in an Australian data centre, and only the question and the excerpts the user is permitted to see go to a named Australian provider that is contractually barred from keeping them or training any model on them. The list of rows to raise at Dr Nair's round is drafted from the register, the residents' records and the home's own register template. Beatriz Santos RN recounts the chemical restraints, leaves each classification to the prescriber and the home, and signs the list.
When is a psychotropic medicine chemical restraint in aged care?
Rule 17-5(2) of the Aged Care Rules 2025 says chemical restraint is the use of medication or a chemical substance for the primary purpose of influencing a person's behaviour. It excludes medication prescribed to treat a diagnosed mental disorder, a physical illness or a physical condition, and medication for end-of-life care. The primary purpose decides it, so the same medicine can be restraint for one resident and treatment for another.
What has to be in place before a home uses chemical restraint?
Under rule 162-25 of the Aged Care Rules 2025, the home must be satisfied that a medical practitioner or nurse practitioner has assessed the risk of harm and the need, prescribed the medication for that purpose and obtained informed consent. The assessments, reasons and prescription details go in the behaviour support plan. Rule 162-15 adds last resort, documented alternatives and the least restrictive form for the shortest time.
What must a home monitor while a resident is on chemical restraint?
Rule 162-30 requires the resident to be monitored for distress or harm, side effects, and changes in mood, behaviour, wellbeing and function, and the need for the practice to be regularly monitored, reviewed and documented. Information about its effects and use goes to the prescribing medical practitioner or nurse practitioner. Using a restrictive practice outside the rules is a reportable incident under section 16(1)(g) of the Aged Care Act 2024.

See Dominion answering from your own documents.

A demonstration takes 30 minutes, uses no client data, and comes with no obligation.

Book a demo